Novo Nordisk (spons. ADRs) Aktie
46,95
EUR
-1,20
EUR
-2,49
%
54,66
USD
-1,08
USD
-1,94
%
Werbung
Novo Nordisk (spons. ADRs) Aktie Analyse
20.06.19 | Novo Nordisk (spons. ADRs) Hold | Deutsche Bank AG | |
11.06.19 | Novo Nordisk (spons. ADRs) Equal weight | Barclays Capital | |
26.07.12 | Novo Nordisk (spons. ADRs) neutral | Exane-BNP Paribas SA | |
08.06.12 | Novo Nordisk (spons. ADRs) neutral | Sarasin Research | |
18.05.12 | Novo Nordisk (spons. ADRs) equal-weight | Morgan Stanley | |
02.05.12 | Novo Nordisk (spons. ADRs) neutral | Exane-BNP Paribas SA | |
07.04.06 | Novo Nordisk (spons. ADRs) Hold | Deutsche Securities |
Werbung
Werbung